MedTrace Logo

Development of Attention and Its Relationship With Emotions in Children and Adolescents

NCT06181747 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2024-03-01

No results posted yet for this study

Summary

Our aim was to describe the development and usability of a mobile device-based game therapy software for ADHD.

Conditions

  • Attention Deficit Disorder With Hyperactivity

Interventions

DEVICE

a serious mobile device-based game prototype (Save the Muse Home)

The cognitive impairment corresponding to the symptoms, which we are interested in, focuses on executive inhibition, motor inhibition, sustained attention, selective attention, working memory, and planning ability. The training content will be presented in different scenarios as effective training components. The story line of the warrior breakthrough runs through the whole game, each level is adapted according to the functional damage areas of different patients, and each level involves reward and punishment mechanisms to keep the interest of the players, the difficulty gradient of each level is kept moderate, and the game includes design elements such as space, time, object attributes, actions, rules, skills, and probabilities, etc., which ultimately completes Save the Muse Home, a serious game for the treatment of ADHD.

Sponsors & Collaborators

  • Institute of Psychology, Chinese Academy of Sciences

    lead OTHER

Principal Investigators

  • Zhengkui Liu, Ph.D. · Institute of Psychology, Chinese Academy of Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-05-05
Completion
2023-05-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06181747 on ClinicalTrials.gov